KYKexin Yang

Kexin Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kexin Yang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Baixiang Wang

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China

    2 shared publications
  • Jiakang Yang

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China

    2 shared publications
  • Fang Wang

    Linping District Hospital of Integrated Traditional Chinese and Western Medicine Hangzhou China

    1 shared publication
  • Feihong Gan

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China

    1 shared publication
  • Huiming Wang

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China

    1 shared publication
  • Katong Lo

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China

    1 shared publication

Latest Publications

  • Stepwise Modified Transcrestal Sinus Floor Elevation in Sites With 3–5‐mm Residual Bone Height: A Retrospective Study

    by Wenjun Duan, Kexin Yang, Katong Lo, Zheyuan Sun, Fang Wang, Feihong Gan, Jiakang Yang, Baixiang Wang

    Objectives: This retrospective study compared the clinical and radiographic outcomes of a stepwise modified transcrestal sinus floor elevation (SM‐TSFE) with the lateral sinus floor elevation (LSFE) for simultaneous implant placement in sites with 3–5 mm of residual bone height (RBH). Materials and Methods: A total of 149 patients with 3–5‐mm RBH underwent simultaneous implant placement using either SM‐TSFE ( n = 69) or LSFE ( n = 80). The follow‐up period ranged from 6 months to 8 years. Evaluated clinical outcomes included implant survival rates, sinus membrane perforation, and postoperative complications. Radiographic assessments included preoperative RBH, marginal bone loss (MBL), and vertical bone height changes. Results: Cumulative implant survival rates were comparable between SM‐TSFE (91.30%) and LSFE (93.75%) groups ( p = 0.537). However, the SM‐TSFE group demonstrated a significantly lower sinus membrane perforation rate (7.24%) compared to the LSFE group (18.75%; p = 0.047). Multivariate analysis identified maxillary sinus septa as the strongest risk factor for perforation ( p = 0.002). Regarding implant failure, TiUnite surface ( p = 0.035) and membrane perforation ( p = 0.039) were significant risk factors, while higher marginal bone height (MBH) was identified as a protective factor ( p = 0.003). Both groups exhibited comparable MBL at 2 years post‐loading ( p > 0.05). Conclusion: In sites with 3–5 mm of RBH, SM‐TSFE provides implant survival rates comparable to LSFE over the observation period but offers a significant safety advantage due to a substantially lower rate of sinus membrane perforation.


  • A Retrospective Study of Clinical Risk Factors and Patient‐Reported Outcomes of Full‐Arch Implant‐Supported Prostheses

    by Xinyue Zhang, Yinlin Wang, Kexin Yang, Xiaoping Qin, Jiakang Yang, Tianle Chen, Shan Yang, Huiming Wang, Baixiang Wang

    Objectives: This study aimed to evaluate clinical outcomes, marginal bone loss (MBL) trends, risk factors, and patient‐reported outcomes (PROs) of immediate full‐arch implant restoration to guide clinical decision‐making. Materials and Methods: A retrospective analysis was conducted on 50 patients with 256 implants who underwent immediate restoration. Clinical and imaging data, implant survival rates, and mechanical complications were analyzed. MBL was measured at five time points using cone beam computed tomography (CBCT): T0 (immediately post‐implantation), T1 (6 months), T2 (1 year), T3 (2 years), and T4 (3–5 years). PROs were assessed using the Oral Health Impact Profile‐14 (OHIP‐14) and the European Five‐Dimensional Health Inventory‐5 L (EQ‐5D‐5L). Results: The implant survival rate was 98%, with an average follow‐up of 42 ± 16.36 months. Mechanical complications occurred in 46% of cases. MBL was most rapid between T0 and T2 and slowed from T2 to T4. Significant risk factors for increased MBL included smoking, maxillary implants, female gender, and advanced age. Furthermore, 30° angled multi‐unit abutments on posterior implants were associated with greater MBL compared to straight (0°) angled abutments. Overall, patients reported high satisfaction with the immediate restoration, as reflected by the OHIP‐14 and EQ‐5D‐5L scores. Conclusions: Immediate restoration with full‐arch implants yields excellent clinical outcomes and improves Oral Health‐Related Quality of Life (OHRQoL). While bone levels tend to stabilize after 2 years, the high incidence of prosthetic complications underscores the critical need for rigorous long‐term maintenance protocols.